PRIMARY STUDY
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Key Findings: This review of the current data (preclinical and clinical) supports that endocannabinoids pay a role in Autism spectrum disorder (ASD), and that cannabidiol (CBD) may provide therapeutic uses in the treatment of symptoms and comorbidities associated with ASD.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Brazil
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD), Endocannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
Citation: Pedrazzi JFC, et al. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?. Psychopharmacology (Berl). 2022; 239:2713-2734. doi: 10.1007/s00213-022-06196-4
Authors: Pedrazzi JFC, Ferreira FR, Silva-Amaral D, Lima DA, Hallak JEC, Zuardi AW, Del-Bel EA, Guimarães FS, Costa KCM, Campos AC, Crippa ACS, Crippa JAS
